Healthy Young WomenIMA-SH & ExercNCT07181044
Exercise, IMA and Sulfhydryl Biomarkers in Young Women
An observational study of Healthy Young Women and Regular Exercise, run by Duvenciler Anadolu Lİsesi at 1 site in Turkey (Türkiye).
Trial summary
Background: Regular physical activity exerts systemic health benefits that extend to redox homeostasis and antioxidant defense mechanisms. Ischemia-modified albumin (IMA) and total sulfhydryl groups (-SH) are increasingly recognized as sensitive biomarkers reflecting oxidative protein modification and thiol-dependent… Read more about this study
- Who is it for?
- Ages 18 to 25 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Healthy Young Women, Regular Exercise, Oxidative Stress
- How many people
- 30 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 20 Jan 2022to 20 Mar 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- Women only
- Healthy volunteers accepted
- Adult
Study population: Thirty healthy women aged 18-25 years were recruited. Fifteen had a history of regular structured exercise training, while fifteen had sedentary lifestyles without structured exercise.
Who may be able to join
- Healthy women aged 18-25 years
- For exercise group: Regular structured training ≥3 sessions per week for at least 12 months
- For control group: No structured exercise background, only daily living activity
Who cannot join
- History of chronic cardiovascular, metabolic, or endocrine disorders
- Smoking or alcohol abuse
- Current or recent use (past 6 months) of medications or supplements influencing oxidative stress or hormonal regulation
- Irregular or intermittent exercise participation not meeting the defined threshold
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Yüzüncü Yıl University, Central Research Laboratory
Van, Muş, 49100
About this study
Official title: Effects of Regular Exercise on Ischemia-Modified Albumin and Total Sulfhydryl Levels in Young Women
Background: Regular physical activity exerts systemic health benefits that extend to redox homeostasis and antioxidant defense mechanisms. Ischemia-modified albumin (IMA) and total sulfhydryl groups (-SH) are increasingly recognized as sensitive biomarkers reflecting oxidative protein modification and thiol-dependent antioxidant capacity, respectively. However, data on their interplay in young women engaged in structured exercise remain scarce.
Objective: This study aimed to investigate the effects of regular exercise on serum IMA and -SH concentrations in healthy young women, thereby providing insights into exercise-induced redox remodeling and sex-specific physiological adaptations.
Methods: A cross-sectional design was employed involving 30 healthy women aged 18-25 years. Participants were divided into an exercise group (n = 15), who had performed structured training ≥3 sessions per week for at least one year, and a control group (n = 15) with no structured exercise history. Venous blood samples were collected after overnight fasting. Serum IMA was quantified using the albumin-cobalt binding assay, and -SH concentrations were determined via the Ellman method. All analyses were performed in duplicate under standardized laboratory conditions. Independent samples t-tests were applied, and effect sizes (Cohen's d) were calculated with 95% confidence intervals.
Read the detailed description
Regular physical activity is widely recognized as a key determinant of human health, conferring benefits across cardiovascular, metabolic, endocrine, and immune systems. Beyond traditional outcomes, habitual exercise plays a pivotal role in regulating oxidative stress and maintaining redox homeostasis. However, few studies have concurrently investigated ischemia-modified albumin (IMA), a marker of oxidative protein modification, and total sulfhydryl groups (-SH), a marker of thiol-dependent antioxidant defense, particularly in young women. The present study was therefore designed to provide novel insights into exercise-induced redox adaptations in this underrepresented population.
This investigation employed an observational, cross-sectional design conducted in accordance with the STROBE guidelines for reporting observational research. Ethical approval was granted by the Muş Alparslan University Scientific Research Ethics Committee (Approval No: 27750; 01 November 2021), and all procedures complied with the Declaration of Helsinki. Written informed consent was obtained from all participants prior to data collection.
A total of 30 healthy women aged 18-25 years were recruited. Participants were categorized into two groups:
Exercise group (n = 15): Women who had been consistently engaged in structured training for at least 12 months, with a minimum frequency of three sessions per week. Training programs were multimodal and typically included aerobic exercise (e.g., running, cycling, swimming at 60-75% HRmax for 20-30 minutes), resistance training (3 sets of 8-12 repetitions at moderate-to-high intensity, targeting major muscle groups), and flexibility exercises incorporated during warm-up and cool-down phases. Training sessions were supervised by qualified instructors in university or private facilities to ensure adherence to safety standards.
Control group (n = 15): Women without a history of structured exercise, whose activity levels were limited to daily living tasks and compulsory school-based physical education.
Exclusion criteria included chronic cardiovascular, metabolic, or endocrine disorders; smoking or alcohol use; recent use of medications or supplements known to influence oxidative stress; and irregular or intermittent exercise participation. Baseline health screening confirmed all participants were free from chronic illness and suitable for inclusion.
Venous blood samples were collected from the antecubital vein between 07:00 and 09:00 a.m. following an overnight fast of at least 10 hours. Participants refrained from strenuous physical activity, alcohol, and caffeine for 24 hours prior to sampling. Serum was separated by centrifugation and stored at -80 °C until analysis.
Ischemia-modified albumin (IMA): Determined using the albumin-cobalt binding assay (Bar-Or method). Absorbance was measured at 470 nm, expressed in absorbance units (ABSU).
Total sulfhydryl groups (-SH): Measured using the Ellman method, based on the reduction of DTNB and expressed as μmol/L.
All analyses were conducted in duplicate, with strict internal quality control procedures, including calibration curves and reagent blanks. A single trained biochemist blinded to group allocation performed all assays to minimize analytical bias.
Statistical analyses were performed using IBM SPSS Statistics 22.0. Normality was assessed using the Shapiro-Wilk test, and group comparisons were made using independent samples t-tests. Effect sizes (Cohen's d) with 95% confidence intervals were calculated to assess the magnitude of differences.
- Conditions
- Healthy Young Women, Regular Exercise, Oxidative Stress, Redox Homeostasis, Antioxidant Defense, Biomarkers
- Keywords
- Ischemia-Modified Albumin, Total Sulfhydryl Groups, Oxidative Stress Biomarkers, Redox Remodeling, Antioxidant Capacity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Exercising Women | Healthy women aged 18-25 years who performed structured exercise training ≥3 sessions per week for at least 12 months. Training programs included aerobic, resistance, and flexibility exercise, each session lasting 60-90 minutes. | |
| Sedentary Controls | Healthy women aged 18-25 years without a history of structured exercise. Physical activity limited to daily living and compulsory school-based physical education classes. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Serum Ischemia-Modified Albumin (IMA)
Change in serum ischemia-modified albumin (IMA) concentration, measured in absorbance units (ABSU) using the albumin-cobalt binding assay.
Measured: Baseline (single fasting blood draw)
Secondary outcomes (1)
Serum Total Sulfhydryl Groups (-SH)
Change in serum total sulfhydryl (-SH) concentration, measured in μmol/L using the Ellman method.
Measured: Baseline (single fasting blood draw)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Sep 2025
- Study start20 Jan 2022
- Primary completion20 Feb 2022
- Study completion20 Mar 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Healthy Young WomenStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Duvenciler Anadolu Lİsesi
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Omer Faruk Bilici, Duvenciler Anadolu Lİsesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07181044
- Sponsor's protocol ID
- 27750
- Other IDs
- 27750
- Acronym
- IMA-SH & Exerc
- Status last verified
- Sep 2025
- First submitted
- 4 Sep 2025
- Last updated
- 23 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data (IPD) will not be shared because the study involved a small sample of healthy young women and includes sensitive biomarker information. Data sharing is restricted by the ethics committee approval and participant consent, which did not authorize public distribution of individual-level data.
Publications
Bilici OF, Kahraman MZ, Turker A, Seyhan S, Sahin MF, Demir H, Acar G, Bilici MF, Soylu C, Sogut T, Bakum A. Effects of regular exercise on ischemia-modified albumin and total sulfhydryl levels in young women: a cross-sectional study. Front Physiol. 2025 Nov 20;16:1719454. doi: 10.3389/fphys.2025.1719454. eCollection 2025.
PubMed 41357165
Study at a glance
From the registry record, last updated by the sponsor on 23 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Regular Exercise on Ischemia-Modified Albumin and Total Sulfhydryl Levels in Young Women
- ClinicalTrials.gov ID
- NCT07181044
- Acronym / sponsor ID
- IMA-SH & Exerc / 27750
- Conditions
- Healthy Young Women, Regular Exercise, Oxidative Stress, Redox Homeostasis, Antioxidant Defense, Biomarkers
- Keywords
- Ischemia-Modified Albumin, Total Sulfhydryl Groups, Oxidative Stress Biomarkers, Redox Remodeling, Antioxidant Capacity
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Duvenciler Anadolu LİsesiUniversity, hospital or other
- Study start
- 20 Jan 2022 (actual)
- Primary completion
- 20 Feb 2022 (actual)
- Study completion
- 20 Mar 2022 (actual)
- First posted
- 18 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background: Regular physical activity exerts systemic health benefits that extend to redox homeostasis and antioxidant defense mechanisms. Ischemia-modified albumin (IMA) and total sulfhydryl groups (-SH) are increasingly recognized as sensitive biomarkers reflecting oxidative protein modification and thiol-dependent antioxidant capacity, respectively. However, data on their interplay in young women engaged in structured exercise remain scarce.
Objective: This study aimed to investigate the effects of regular exercise on serum IMA and -SH concentrations in healthy young women, thereby providing insights into exercise-induced redox remodeling and sex-specific physiological adaptations.
Methods: A cross-sectional design was employed involving 30 healthy women aged 18-25 years. Participants were divided into an exercise group (n = 15), who had performed structured training ≥3 sessions per week for at least one year, and a control group (n = 15) with no structured exercise history. Venous blood samples were collected after overnight fasting. Serum IMA was quantified using the albumin-cobalt binding assay, and -SH concentrations were determined via the Ellman method. All analyses were performed in duplicate under standardized laboratory conditions. Independent samples t-tests were applied, and effect sizes (Cohen's d) were calculated with 95% confidence intervals.
Detailed description
Regular physical activity is widely recognized as a key determinant of human health, conferring benefits across cardiovascular, metabolic, endocrine, and immune systems. Beyond traditional outcomes, habitual exercise plays a pivotal role in regulating oxidative stress and maintaining redox homeostasis. However, few studies have concurrently investigated ischemia-modified albumin (IMA), a marker of oxidative protein modification, and total sulfhydryl groups (-SH), a marker of thiol-dependent antioxidant defense, particularly in young women. The present study was therefore designed to provide novel insights into exercise-induced redox adaptations in this underrepresented population.
This investigation employed an observational, cross-sectional design conducted in accordance with the STROBE guidelines for reporting observational research. Ethical approval was granted by the Muş Alparslan University Scientific Research Ethics Committee (Approval No: 27750; 01 November 2021), and all procedures complied with the Declaration of Helsinki. Written informed consent was obtained from all participants prior to data collection.
A total of 30 healthy women aged 18-25 years were recruited. Participants were categorized into two groups:
Exercise group (n = 15): Women who had been consistently engaged in structured training for at least 12 months, with a minimum frequency of three sessions per week. Training programs were multimodal and typically included aerobic exercise (e.g., running, cycling, swimming at 60-75% HRmax for 20-30 minutes), resistance training (3 sets of 8-12 repetitions at moderate-to-high intensity, targeting major muscle groups), and flexibility exercises incorporated during warm-up and cool-down phases. Training sessions were supervised by qualified instructors in university or private facilities to ensure adherence to safety standards.
Control group (n = 15): Women without a history of structured exercise, whose activity levels were limited to daily living tasks and compulsory school-based physical education.
Exclusion criteria included chronic cardiovascular, metabolic, or endocrine disorders; smoking or alcohol use; recent use of medications or supplements known to influence oxidative stress; and irregular or intermittent exercise participation. Baseline health screening confirmed all participants were free from chronic illness and suitable for inclusion.
Venous blood samples were collected from the antecubital vein between 07:00 and 09:00 a.m. following an overnight fast of at least 10 hours. Participants refrained from strenuous physical activity, alcohol, and caffeine for 24 hours prior to sampling. Serum was separated by centrifugation and stored at -80 °C until analysis.
Ischemia-modified albumin (IMA): Determined using the albumin-cobalt binding assay (Bar-Or method). Absorbance was measured at 470 nm, expressed in absorbance units (ABSU).
Total sulfhydryl groups (-SH): Measured using the Ellman method, based on the reduction of DTNB and expressed as μmol/L.
All analyses were conducted in duplicate, with strict internal quality control procedures, including calibration curves and reagent blanks. A single trained biochemist blinded to group allocation performed all assays to minimize analytical bias.
Statistical analyses were performed using IBM SPSS Statistics 22.0. Normality was assessed using the Shapiro-Wilk test, and group comparisons were made using independent samples t-tests. Effect sizes (Cohen's d) with 95% confidence intervals were calculated to assess the magnitude of differences.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Exercising Women | – | –Healthy women aged 18-25 years who performed structured exercise training ≥3 sessions per week for at least 12 months. Training programs included aerobic, resistance, and flexibility exercise, each session lasting 60-90 minutes. |
| Sedentary Controls | – | –Healthy women aged 18-25 years without a history of structured exercise. Physical activity limited to daily living and compulsory school-based physical education classes. |
Who may qualify
- Ages
- 18 to 25 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Thirty healthy women aged 18-25 years were recruited. Fifteen had a history of regular structured exercise training, while fifteen had sedentary lifestyles without structured exercise.
Key inclusion criteria (3 listed)
- Healthy women aged 18-25 years
- For exercise group: Regular structured training ≥3 sessions per week for at least 12 months
- For control group: No structured exercise background, only daily living activity
Key exclusion criteria (4 listed)
- History of chronic cardiovascular, metabolic, or endocrine disorders
- Smoking or alcohol abuse
- Current or recent use (past 6 months) of medications or supplements influencing oxidative stress or hormonal regulation
- Irregular or intermittent exercise participation not meeting the defined threshold
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Serum Ischemia-Modified Albumin (IMA)
Time frame: Baseline (single fasting blood draw)
Change in serum ischemia-modified albumin (IMA) concentration, measured in absorbance units (ABSU) using the albumin-cobalt binding assay.
1 secondary outcome
Serum Total Sulfhydryl Groups (-SH)
Time frame: Baseline (single fasting blood draw)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Sep 2025.
- Derived from this study: PubMed 41357165Bilici OF, Kahraman MZ, Turker A, Seyhan S, Sahin MF, Demir H, Acar G, Bilici MF, Soylu C, Sogut T, Bakum A. Effects of regular exercise on ischemia-modified albumin and total sulfhydryl levels in young women: a cross-sectional study. Front Physiol. 2025 Nov 20;16:1719454. doi: 10.3389/fphys.2025.1719454. eCollection 2025.
- Individual participant dataSharing planned: No. Individual participant data (IPD) will not be shared because the study involved a small sample of healthy young women and includes sensitive biomarker information. Data sharing is restricted by the ethics committee approval and participant consent, which did not authorize public distribution of individual-level data.
Related trials for Healthy Young Women
RecruitingObservational study
Postprandial Glucose Handing in Contraceptive and IUD Users
Glucose Homeostasis
Recruiting
The Influence of Plan B® on Cardiovascular Health.
Female, Premenopausal
Active, not recruiting
Guys/Girls Opt for Activities for Life Trial (GOAL) to Increase Young Adolescents' Physical Activity and Healthy Eating
Obesity, Adolescent
Recruiting
Young Athlete Body Project - Prevention of Body Dissatisfaction and Eating Disorders Among Adolescent Athletes
Eating Disorders in Adolescence, Body Dissatisfaction
Recruiting
Effects of Exercise Frequency on Muscle Size and Strength in Healthy, Untrained Young Adults
Healthy Adult Male and Female Volunteers
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Healthy Young Women and Regular Exercise, run by Duvenciler Anadolu Lİsesi at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Serum Ischemia-Modified Albumin (IMA) (time frame: Baseline (single fasting blood draw)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07181044, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2025.